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ABSTRACT
Background: The laparoscopic management of suspi-
cious adnexal masses and early ovarian malignancies is dis-
cussed with the aim of maintaining accepted oncologic
treatment principles. Comparative survival data of patients
with gynecological malignancies managed by laparoscopy
or laparotomy are still very scarce and the survival of can-
cer patients must not be compromised by new techniques.
It is time to closely analyze laparoscopy and determine if it
has a positive impact on the diagnosis and treatment of
ovarian malignancies. In this paper we will address the fol-
lowing points:
1) Which ovarian cysts can be surgically treated by
laparoscopy (pelviscopy)?
2) Is staging laparoscopy an accepted technique?
3) Is laparoscopy, as a second-look procedure, of
benefit?
4) Is laparoscopic staging, together with histologic
tissue sampling, adequate surgical technique in
inoperable ovarian cancer with ascites and peri-
toneal carcinomatosis?
5) Does endoscopic biopsy of ovarian cancer stage Ia
change the destiny of a patient into ovarian cancer Ic?
Data Base: The above questions are analyzed based on
our experience with the laparoscopic treatment of 1,225
patients with ovarian cysts and 165 ovarian cancer patients
stage I to IV treated immediately by laparotomy during the
years 1992-1995.
Conclusions: Ovarian cystic tumors with no signs of
malignancy can be dealt with by laparoscopic means with
the option of immediate conversion to laparotomy or with-
in one week if an ovarian malignancy is diagnosed. Today
sampling laparoscopic lymphadenectomy of both pelvic
and para-aortic is feasible and adequate. On a curative
level, the number of lymph nodes to be resected has yet to
be determined. The adnexa can be extracted from the
abdominal cavity with bag extraction without the danger of
spillage. The uterus can be removed transvaginally with
laparoscopic assisted vaginal hysterectomy (LAVH). We
must be cautious to advocate laparoscopy for ovarian can-
cer. However, it is an excellent tool when used as a stag-
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ing procedure. A careful preoperative screening of the
patient and an exact definition of existing cysts with imag-
ing techniques allows us to frequently apply laparoscopic
surgery for ovarian cysts, leaving only readily detectable
cancer cases for laparotomy. Many gynecological oncolo-
gists employing staging and second-look procedures for
ovarian cancer agree that initiating a case with laparoscopy
may preclude laparotomy for many patients. Tumor propa-
gation by performing a biopsy in FIGO stage Ia ovarian
cancer patients does not occur if the patient receives ade-
quate radical surgical treatment within one week.
According to the reports of Sevelda et al. and Dembo et al.,
the degree of differentiation and the existence of ascites are
more relevant to decreasing the five-year survival rate of
patients with ovarian cancer stage I than the rupture of cap-
sule or penetration of the tumor.
16,1
7 A dependency on the
first two parameters was found in these two large statistical
studies.
As the question of endoscopic operations for adnexal mass
is predominantly put for the sanitation of small ovarian
tumors (ovarian tumors with solid particles in the cysts can
be put into the section of primary laparotomies) there
remains a wide field of indications for the laparoscopic
treatment of adnexal mass and ovarian cysts with benign
indications. For many young patients with non-malignant
ovarian lesions such as endometriosis, benign cysts, benign
cystic proliferations and fibromas, a laparotomy can be
avoided and these lesions treated by laparoscopy.
Key Words: Laparoscopy, Adnexal mass, Ovarian malig-
nancy, Second-look laparoscopy.
INTRODUCTION
Ovarian tumors occur in all stages of female life: during
childhood they arise mostly as dysgerminomas; after menar-
che as functional cysts; and around menopause as carcino-
mas, although carcinomas also appear during reproductive
age. The histological picture of ovarian tumors is quite
characteristic, but the exact histological classification is often
difficult to determine as ovarian tumors may grow very
rapidly. A precise early diagnosis is not always possible.
The spectrum of therapy for ovarian cancer has changed a
great deal over the past several years as more radical oper-
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Table 1.
Prerequisites in Judging Ovarian Cysts Prior to Laparoscopic Surgery
Ultrasound
Tumor markers
Size of cyst
Hematological
parameters
In some cases
vaginal
abdominal
Doppler
3 dimensional
CA 125
larger than 15 cm in diameter
difficult to judge
NMR - nuclear magnetic resonance
CT - computer tomogram
no solid - echo dense structures
(exception dermoid cyst)
always in-patients > 40 years
ations are performed in the early stages of the disease, new
chemotherapeutic strategies with agents such as paclitaxel
have been initiated, and stem cell transplantation during
high dose chemotherapy has been investigated. However,
the general prognosis remains poor. Only women with an
early ovarian cancer, stage I, which is not easily discovered,
have a significant chance for survival. In order to guaran-
tee the healing process, surgical procedures for ovarian
tumors have to be performed as carefully as possible. The
oncologic principles of ovarian surgery have to be applied
during laparoscopic surgery. Unfortunately the rupture of
an ovarian cancer stage Ia during laparoscopy, as in laparo-
tomy, sometimes cannot be avoided. Since the beginning
of the 1980s, world-wide laparoscopic procedures have
increased and the question of tumor dissemination, espe-
cially in ovarian cancer, is being newly discussed.
For those gynecologic oncologists employing second-look
procedures it appears that beginning with laparoscopy may
preclude laparotomy in many patients. Therefore, it has
been frequently suggested that the role of laparoscopy as a
second-look procedure in ovarian cancer can avoid laparo-
tomy. Comparative survival data for patients with gyneco-
logical malignancies managed by laparoscopy or laparoto-
my, however, are still very scarce. Sound surgical practice
and medical ethics demand that the survival of patients
must not be compromised by the investigation of new tech-
niques.
Historical Background:
Very little has been published concerning the role of
laparoscopy in patients with invasive ovarian carcinoma. In
the late 1970s and early 1980s laparoscopy was used for
pre-treatment evaluation (in patients whose initial staging
laparotomy was felt to be inadequate) to replace a staging
laparotomy in patients with presumed stage III and IV dis-
ease. Laparoscopy could detect diaphragmatic metastases
in a significant number of patients and be applied in a far
more precise way than laparotomy.
1 In Bagley's series of
cases suspicious for ovarian cancer, metastases were dis-
covered in 62.5% of patients (10 of 16) who were original-
ly felt to have stage I or stage II ovarian cancer.
2
Semm, along with others, suggested laparoscopy for a sec-
ond-look procedure in ovarian cancer,
 1,3,4 Although the
identification of persistent disease, as based on second-look
laparotomies, was lower than expected in these early
reports, the technique is advised if the whole abdomen is
visible laparoscopically. If the entire abdomen is not visi-
ble one can always convert to a laparotomy. None of the
early investigators sampled pelvic or para-aortic lymph
nodes. We always suggested routine blind biopsies and
abdominal washings. The importance of washings for cyto-
logical evaluations has been reported by several investiga-
tors.
5
Basic Principles:
In women beyond the menopausal age an adnexectomy is
the procedure of choice for the prevention of rupture in
those with an ovarian tumor. During the reproductive
years we primarily have to think of treating cystic ovarian
structures to preserve the ovaries and to preoperatively
exclude cancer. In the early 1990s, laparoscopic proce-
dures for ovarian surgery reported a 2-4% incidence of
ovarian cancer cases, which were biopsied and subse-
quently underwent definitive surgical treatment. It is felt
that this number can be reduced to 0.2-0.6% with intensive,
thorough preoperative testing. Each ovarian tumor should
104 JSLS(1997)1:103-112Figure 1. Pelviscopic enucleation of an ovarian cyst and suture of the ovarian lining.
1. Capsular incision
2. Cyst resection
3. Ovarian suture
4. Final aspect after endoscopic ovarian cyst resection
Figure 2. Bag extraction of endoscopically resected adnexa.
1. Positioning of adnexa into an endobag
2. Closing the bag by pulling the string
3. Insertion of bag into the trocar
4. Bag extraction
be investigated preoperatively with all available imaging
methods, so that laparoscopy for the surgical correction of
functional cysts can be avoided.
Preoperative Diagnosis:
Prior to therapy an extensive and wide anamnesis and clin-
ical investigation is necessary to establish a differential
diagnosis. Endometriotic cysts are differentiated from car-
cinomas. This is performed by careful ultrasound diagno-
sis transvaginally and, if available, with Doppler ultrasound
and three-dimensional ultrasound. Special consideration
has to be given to the tumor size, to the presence of uniloc-
ular or bilateral ovarian cysts, the existence of septa, the
existence of solid particles, papillomatous structures, hema-
tological hints for malignancies, etc. The result of ultra-
sound is put together as sonomorphology with a diagnosis
towards dignity or malignancy. Tumor markers, especially
CA 125, have a special predictive value in premenopausal
patients. False positive values are expected in cases of
endometriosis and uterine fibromas. During the post-
menopausal period, endometriosis and uterine fibromas
have a certain draw towards malignancies. Prerequisites
for a planned ovarian surgery in benign cysts are the fol-
lowing items (Table 1).
Intraoperative Diagnosis:
Intraoperatively, after initial laparoscopic survey, the situa-
tion is evaluated with loop augmentation or video magnifi-
cation. In cases of suspected malignancy the surgical pro-
cedure is converted into a laparotomy. Intraoperatively,
one has the capability of taking a fluid sample from the
pouch of Douglas for cytological examination and per-
forming a careful look for metastases. An opening of cysts
for diagnostic purposes is not recommended as this could
provoke cell dispersion in cases of malignancy. The result
of cytological examination of fluid from the pouch of
Douglas should be available prior to manipulation of ovar-
ian tumors, if the surgeon has any suspicion of malignan-
cy. That is to say if the surface of the ovary shows
increased vascularization or other changes that suggest the
possibility of malignant tumor, conversion to laparotomy
should occur even if the histology does not later show a
malignancy.
In the case of minor alterations on the surface of the ovary,
a biopsy should be taken and a histological diagnosis done
intraoperatively. The frozen section, however, can present
difficulties for the pathologist. If a clear-cut diagnosis can-
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Figure 3. Endoscopic ovarian
cyst resection in a series of pic-
tures.
1. Ovarian cyst to the right side
2. Cyst resection
3. Cyst inspection
4. Ovarian suture
5. Endobag extraction
not be given or if the diagnosis does not fit the anatomical
situation, it is better to stop the surgery, not to go to laparo-
tomy but wait for the final histology. Once the histology is
clear, laparoscopic adnexectomy or laparotomy has to be
performed at that time during the same operation. In cases
of malignancies, the extended open (laparotomy) surgery,
if not performed at the same intervention, must be per-
formed within one week of the primary diagnosis.
Laparotomy performed later carries the risk of having
delayed too long.
If there is no sign of malignancy, the ovarian tumor is
resected according to the age and life situation of the
patient. During an adnexectomy, an ovariectomy, partial
ovariectomy or cystectomy, all ovarian tumors should be
precisely excised. This is also difficult during laparotomy
but must be considered if one wishes to preserve the organ.
The extraction of the ovarian tumor must be into an appro-
priate endoscopic bag, which is passed through a working
channel through the abdominal layers. As impermeable
bags are readily available, the extraction of an unprotected
ovarian tumor through the trocar is no longer appropriate.
After extirpation of the specimen, hemostasis may be
secured by coagulation, use of sutures or by clips followed
by an adequate rinsing and aspiration procedure leaving
clear wound conditions.
Functional Cysts:
In order to avoid unnecessary operations for functional cys-
tic ovarian tumors, all patients should be managed initially-
with an estrogen suppressive treatment program.
Prerequisites are the existence of one or two chamber cysts
smaller than five centimeters in diameter and causing no
pain to the patient. It is easy to follow the cyst by vaginal
ultrasound examinations at intervals of no longer than four
weeks. If the cysts increase in size, change their shape or
do not diminish in size, the patients should be operated
upon according to the criteria described for laparoscopy or
laparotomy. An increase in size as well as an increase in
abdominal pain calls for immediate surgical intervention.
Treatment of Ovarian Tumors at the Department
of Obstetrics and Gynaecology, University of Kiel
1992-1995:
Endoscopic surgical procedures were performed in 1,225
patients who presented cystic ovarian tumors between 1992
and 1995 at the Department of Obstetrics and
Gynaecology, University of Kiel. One hundred and sixty-
five new patients with ovarian cancer stage I to IV were
treated according to accepted criteria with an operative rad-
ical laparotomy debulking, lymphadenectomy and omen-
tectomy. Consecutive chemotherapeutic courses or radia-
tion therapy were given according to accepted parameters.
The operative procedure mandated in our institution is that
of direct laparotomy in cases of possible malignancies. In
the cases presented during these four years none of the
endoscopically performed biopsies and frozen sections
suggested an ovarian cancer. If biopsy would have indi-
cated a malignancy, we would have performed the corre-
sponding radical operation during the same surgical proce-
dure after converting to laparotomy. We converted more
cases to laparotomy than necessary in order to take a biop-
sy. Laparoscopic transabdominal extraction of an adnexec-
tomy, an ovariectomy or an ovarian cyst resection, was
always performed in an endobag.
Figures 1 to 3 demonstrate ovarian cyst resection and
adnexal bag extraction via laparoscopy (pelviscopy) in line
106 JSLS (1997)1:103-112Figure 4a. Endoscopic oophorectomy using the 3-loop ligation technique in four steps.
1. Positioning of the frist Roeder loop
2. After placement of 3 loops ovarian resection
3. Endocoagulation of the ovarian stump
4. Ovarian morcellation using 15 or 20 mm trocars
Figure 4b. Endoscopic adnexectomy using the 3-loop ligation technique in four steps (1-4) or in three steps using
stapling techniques (A-C).
1. Placement of first loop
2. Cutting the loop
3. After positioning of 3 loops adnexal resection
4. Endocoagulation of the stump
A. Adnexal resection using a stapling device
at the ovarian ligamnet
B. Dissection of infundihulo pelvic ligament
C. Adnexal resection
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Ovarian Cysts '92-'95
Figure 5. Statistical evaluation of 1225 patients treated by endoscopic ovarian surgery according
to their ages, size of ovarian cysts, color of cyst fluid and uni- or bilateral localization.
drawings as well as endoscopic pictures. Oophorectomies
Figure 4a or adnexectomies Figure 4b were performed
with the three-loop suture ligation technique, by stapling
devices or after bipolar coagulation of the ovarian ligament.
All these techniques facilitate an easy adnexectomy, which
was predominantly performed in patients beyond the
reproductive age. Figure 5 details the operative patients
according to their ages, the size of the ovarian cyst, if the
cysts were septated, if they contained clear or bloodstained
fluid and if they were unilateral or bilateral. Histological
results revealed the broad spectrum of diagnosis and also
included functional cysts of patients who were referred to
us by their doctors for persistent ovarian cysts. Carcinomas
were detected in 2.4%. Figure 6 specifies the patients in
1992, 1993, 1994 and 1995 in which we converted the oper-
ation into a laparotomy. However, of those patients only
two in 1992, five in 1993, two in 1994 and four in 1995
eventually presented with malignancies. Figure 7 details
the benign and malignant patients who were diagnosed as
suspect at the first-look staging laparoscopy. Figure 8
gives the histological results of nine patients who did pre-
sent malignancies after conversion to laparotomy. These
cancers were not recognized preoperatively but during the
conversion to laparotomy. In one case, laparoscopic biop-
sy of the ovary revealed a borderline lesion. Only later in
the histopathological evaluation of the paraffin section was
the diagnosis of a non-Hodgkin's lymphoma confirmed.
We do not intend to say that we will never find a malig-
nancy when we do a biopsy laparoscopically, but it will
happen rarely. Had we continued in the above patient
with a borderline lesion, we would not have performed the
correct therapy. The diagnosis, which was received not at
frozen section but two days later, revealed a Hodgkin's
lymphoma. The patient then received the adequate treat-
ment. The frozen sections indicated a borderline lesion
which did not seem to fit the picture of that patient.
Therefore, in this case we waited for the final diagnosis and
elected to perform a laparotomy after we had the final
result two days later. The Hodgkin's lymphoma then
required a different treatment.
Patients treated endoscopically should follow the principles
of open oncologic surgery. The tumors should be taken
out without rupture of the capsule and without contamina-
tion. Considering these regulations, staging endoscopic
surgery with the possibility of converting to laparotomy in
the few specific cases that reveal ovarian cancer does not
present a higher risk for the patient than primary laparoto-
my. Any consecutive radical operation has to be done
immediately or within the first week of diagnosis. This
includes all malignant adnexal tumors, ovarian cancer, tubal
cancers, dysgerminomas, malignant teratomas and border-
line cancers of the ovary. According to current oncologic
criteria, an endoscopic biopsy of malignant adnexal tumors
should be avoided. In patients with non-suspicious lesions
preoperatively, a laparoscopic biopsy may be indicated.
The appropriate consecutive operation has to follow with-
in the discussed time limit. The question arises whether in
a 25-year-old patient undergoing infertility treatment should
one do a biopsy of a pea-sized abnormal looking ovarian
lesion or take out the whole ovary at laparotomy.
108 JSLS (1997)1:103-112However, in such a young patient, even at a laparotomy,
one would hesitate to do more than a biopsy at the prima-
ry intervention.
For these cases we would like to propose the
following:
If there is a suspicion of a non-benign lesion of the ovary
prior to and after laparoscopy, serological examination
of a fluid sample from the pouch of Douglas should be
performed.
Frozen section is indicated for unexpected, potentially
malignant alterations in an ovarian cyst.
With unexpected malignant lesions, the patient has to be
operated on during the same intervention with defini-
tive resection of ovaries, adnexa, uterus, lymph nodes
and omentum, or at least within the next five days.
In all patients with an ovarian cyst, explanation prior to the
operation must include a discussion of malignant alter-
ations that may require a laparotomy with hysterectomy,
bilateral adnexectomy, omental resection and possibly
lymphadenectomy.
With unexpected suspicious lesions (and a well-informed
patient) the diagnosis is confirmed with a biopsy; the
corresponding laparotomy has to follow within the next
five days.
Endoscopic organ extraction of an adnexal tumor has to be
performed with an impermeable endobag.
If in spite of the described security examinations or pre-
requisites for endoscopic ovarian surgery an ovarian cancer
has been biopsied, depending on the stage it has to be
operated as quickly as possible and followed by
chemotherapy. This has to be done within one week of the
first procedure.
The Role of Laparoscopy in Stage I Ovarian
Carcinoma:
The role of laparoscopy in stage I ovarian carcinoma has
been addressed by different authors. Some surgeons have
incorporated the use of routine procurement of washings
and blind biopsies in their staging procedures. Of great
Figure 6. Conversion rate of pelviscopy to laparotomy
between 1992-1995 at ovarian endoscopic surgery.
Figure 7. Suspect diagnosis at pelviscopic screening for
ovarian surgery.
Specification of ovarian malignancies
1992-1995
1992
1 X adenocarcinoma
1 X granulosacell-
tumor with sarcoma
1993
3 X adenocarcinoma
1 X Krukenbergtumor
1 X metastasis of
non-Hodgkin lymphoma
1994
3 X adenocarcinoma
1 X Krukenbergtumor
1995
4 X adenocarcinoma
Figure 8. Specification of ovarian malignancies screened endoscopically but treated sur-
gically by laparotomy.
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importance is the possibility of magnification with video
laparoscopy and the ability to perform pelvic and para-aor-
tic lymphadenectomy. This makes laparoscopic staging
potentially a very accurate technique. At the present time
there are only a few case reports available describing
laparoscopic staging of estimated stage I invasive carcino-
ma of the ovary. Reich et al. (1990) were the first with their
report of a 56-year-old woman with a five-centimeter left
ovarian neoplasm. After removing the adnexa through a
colpotomy incision and confirming malignancy by a frozen
section, they performed a laparoscopic assisted vaginal hys-
terectomy and right salpingo-oophorectomy along with a
transvaginal infra-colic omentectomy, a left pelvic lym-
phadenectomy and biopsy of the left pelvic sidewall. The
histological examination showed both ovaries contained
grade II serous papillary adenocarcinoma but 11 pelvic
nodes and pelvic sidewall biopsies were all negative for
malignancy. This group has been criticized for puncturing
a malignant cyst, not obtaining intraperitoneal washings for
cytology or multiple blind biopsies, especially of the right
hemidiaphragm, and not sampling para-aortic lymph
nodes. However, they should also be congratulated for
their innovativeness in using this technique in a patient
who refused laparotomy. In 1992, Nezhat and colleagues
reported on four ovarian cancers diagnosed during laparo-
scopic management of 1,011 women with adnexal masses.
7
In this series they described a six-centimeter right ovarian
cyst that was opened and biopsied for papillary growth and
revealed necrotic tissue with atypical glands. They per-
formed a right salpingo-oophorectomy, appendectomy and
peritoneal and omental biopsies laparoscopically.
Querleu outlined what is today considered an adequate
laparoscopic surgical staging procedure for ovarian carci-
noma. In his report, he described laparoscopic infrarenal
para-aortic node dissection in a 39-year-old woman with a
serous tumor of low malignant potential.
8 He successfully
staged this patient laparoscopically by oncologic standards
and performed washings, multiple biopsies, omentectomy
and a pelvic and para-aortic lymphadenectomy. Twelve
pelvic lymph nodes, nine para-aortic lymph nodes and all
biopsies were negative for metastatic disease. In 1994
Querleu and Le Blanc reported on laparoscopic infrarenal
para-aortic node dissection for staging of carcinoma of the
ovary or Fallopian tube.
9 Four patients with presumed
stage la ovarian cancer of low malignant potential were
restaged following inadequate staging procedures. Three
other patients had invasive cancer and were staged laparo-
scopically for presumed stage I disease. Endometrioid can-
cer of the ovary was found in two patients and one patient
had a Fallopian tube carcinoma. They described an ade-
quate staging procedure including pelvic and para-aortic
lymphadenectomy up to the renal veins, with an average of
10 para-aortic lymph nodes to be removed. Many staging
laparotomies performed, for example, at our department
do not include such a detailed field. Childers et al. in 1992
and in 1993 described para-aortic lymphadenectomies and
gynecological malignancies in 18 patients with ovarian can-
cer.
1
0 In the majority of patients these were second-look
procedures for advanced disease, but in six patients they
presumed stage I ovarian cancer. It is of great concern that
laparoscopic staging of presumed stage I ovarian carcino-
ma may miss extra ovarian disease that would have been
detected at laparotomy. As the screening possibility with
the 4-8 times magnification during laparoscopy in an adhe-
sion-free abdomen is even better than that at a laparotomy,
this concern is unnecessary.
Fifteen years ago we already started to use video
laparoscopy primarily for second-look procedures for
advanced disease prior or during chemotherapy. We inves-
tigated the effectiveness of laparoscopy in this combination.
Laparoscopic Diagnosis and Surgery in Advanced
Ovarian Cancer and Second-look Laparoscopies:
Whenever possible advanced ovarian carcinoma should be
treated with a primary debulking laparotomy. In cases of
an ovarian cancer without enlargement of the tumor with-
in the minor pelvis, laparoscopic diagnosis and histological
verification is justified. Especially in those cases with
ascites, however, it must be possible to perform either a
laparotomy with radical surgery including deperitonization,
bowel resection, omentectomy, etc., or chemotherapy
immediately after diagnosis. These interventions must be
done in oncologic centers that have the infrastructure for
radical operations and adequate medical therapy of ovari-
an carcinomas.
Our present experience of second-look laparoscopies has
not been previously reported and consists of 62 interven-
tions performed on 48 patients with advanced ovarian car-
cinomas. All patients were primarily operated on with
maximal surgical debulking and had received platinum-
based chemotherapy. Clinically, they showed no evidence
of malignant disease. All tumor-markers were negative (CA
125) with the exception of four cases. If at laparoscopy no
obvious disease was noted immediately, intraperitoneal
washings were obtained and slices of adhesions and biop-
sies were taken of many suspicious and non-suspicious
areas. Persistent disease was documented laparoscopically
in 20 of our 62 procedures. Only in seven patients did we
find metastatic disease with intraperitoneal metastases. In
five patients we had to convert to laparotomy as the
abdominal cavity, even after adhesiolysis, was not really
visible. Our results of second-look laparoscopies are
encouraging. We could avoid a laparotomy in over 90% of
our patients. The positive rate was similar to that found at
second-look laparoscopies, and the patients certainly had
a shorter hospitalization time and less physical pain than in
HO JSLS(1997)1:103-112Table 2.
Possibilities of judgement at pelviscopy/upper
abdominal laparoscopy.
Ovarian surface texture
Vascularization of tumor
Papillomatous or suspicious structures
Adhesions
Ascites
Cytology in rinsing fluid
Tumor sites at the peritoneum, intestines, liver, diaphragm
Size of primary tumor
Mobilization of tumor
Amount of adhesions of intestines
Mobilization of intestines
Indication for laparotomy with the possibility of 90%
tumor reduction
Biopsy of primary tumor, peritoneum,
omentum, intestines, liver diaphragm
a repeat laparotomy. In these patients to date, only two
lymphadenectomies have been performed. However, with
growing experience this should be included more often
into our second-look laparoscopies. As reported by
Childers in 1995 in a series of 42 procedures performed in
38 patients with advanced ovarian or Fallopian tube carci-
noma in second-look laparoscopies, if no persistent disease
was documented by frozen section, they performed multi-
ple blind biopsies and laparoscopic lymphadenectomy rou-
tinely.
11,1
2 With this combination of procedures at second-
look laparoscopy they found a 58% positive rate, which is
similar if not higher than the reported rate for second-look
laparotomy. Extrapolating these data, they presumed one
could infer that laparoscopic staging of presumed early
ovarian carcinoma would disclose metastatic disease at a
rate similar to that of laparotomy.
1
3 Dargent in 1993 and
Spirtos in 1993 described laparoscopic interventions in
gynecological cancer as clear-cut alternatives to laparoto-
my.
14,1
5
Structural Prerequisites for Laparoscopic
Operations of Ovarian Tumors:
Ovarian tumors in which malignancy has been excluded by
preoperative diagnosis can be operated on where the per-
sonal and apparative prerequisites for laparoscopic opera-
tions are present. In all other cases, however, if one can-
not exclude malignancy and possible laparotomy based on
the preoperative investigations, intervention should be car-
ried out at clinics where the prerequisites for an adequate
and correct surgery for laparotomy are present.
CONCLUSION
As already indicated in the catalogue of indications for
advanced laparoscopic surgery by Semm in 1984, diagnosis
and therapy of ovarian cancer by laparoscopy can be con-
sidered. First reports on the role of laparoscopy in gyne-
cological malignancies have centered around staging pro-
cedures and second-look laparoscopies. Today, regarding
tissue sampling, laparoscopic lymphadenectomy of both
pelvic and para-aortic nodes is feasible and adequate. On
a curative level the number of lymph nodes to be resected,
however, has yet to be determined. We must be cautious
to advocate laparoscopy for ovarian cancer treatment; how-
ever, it is a valuable and worthwhile tool in the staging of
malignancies. Careful preoperative screening of the patient
and an exact definition of existing cysts with imaging tech-
niques allows us to frequently apply laparoscopic surgery
for ovarian cysts, leaving only readily detectable cancer
cases for laparotomy.
It may be safe to say that gynecological oncologists
employing staging and second-look procedures for ovarian
cancer have to admit that beginning with laparoscopy may
preclude laparotomy for many patients. Survival data for
patients with gynecological malignancies managed by
laparoscopy instead of laparotomy are of course still lack-
ing and this is the predominant question. In no way must
survival be compromised just to employ a new surgical
technique. According to the reports of Sevelda et al. and
Dembo et al., the degree of differentiation and the exis-
tence of ascites are more relevant to decreasing the five-
year survival rate after ovarian cancer stage I than the rup-
ture of capsule or the penetration of the tumor. A depen-
dency on the first two parameters was found in two large
statistics.
16,1
7
As the question of endoscopic operations in adnexal mass
is predominantly put for the sanitation of small ovarian
tumors (ovarian tumors with solid particles in the cysts can
be put into the section of primary laparotomies), there
remains a wide field of indications for the laparoscopic
treatment of adnexal mass and ovarian cysts with benign
indications. For many young patients with non-malignant
ovarian lesions such as endometriosis, benign cysts, benign
cystic proliferations and fibromas, a laparotomy can be
spared and they can be treated by laparoscopy. The
laparoscopic therapeutic management of ovarian malignan-
cy and suspicious adnexal masses cannot be recommend-
ed at the present time, but must be investigated by careful-
ly controlled studies. Different possibilities of judgement at
pelviscopy including upper abdominal laparoscopy are
given and have to be included in any discussion (Table 2)
on the laparoscopic treatment of ovarian cysts.
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